MedTrace Logo

Causes of Pneumonia in Yangon

NCT03578133 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-01-13

No results posted yet for this study

Summary

This study will evaluate a new point of care diagnostic test for the diagnosis of melioidosis pneumonia in patients attending outpatient clinics in Yangon, Myanmar

Conditions

  • Melioidosis Pneumonia

Interventions

DIAGNOSTIC_TEST

InBios® Active Melioidosis DetectTM-Lateral Flow Assay

Evaluation of a lateral flow assay for the detection of B.pseudomallei 6-deoxyheptan capsular polysaccharide antigen from sputum

Sponsors & Collaborators

  • Medical Action Myanmar

    collaborator OTHER

  • Department of Medical Research, Myanmar

    collaborator UNKNOWN

  • Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit

    collaborator OTHER

  • Myanmar Oxford Clinical Research Unit

    lead OTHER

Principal Investigators

  • Elizabeth A Ashley, Dr · Myanmar Oxford Clinical Research Unit

  • Frank Smithuis, Prof · Myanmar Oxford Clinical Research Unit and Medical Action Myanmar

  • Clare Warrell, Dr · Myanmar Oxford Clinical Research Unit and Medical Action Myanmar

  • David Dance, Prof · Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit

  • Ni Ni Tun, Dr · Medical Action Myanmar

  • Mo Mo Win, Dr · Department of Medical Research, Myanmar

  • Alistair McLean, Dr · Myanmar Oxford Clinical Research Unit

  • Kyaw Soe · Myanmar Oxford Clinical Research Unit

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-09
Primary Completion
2019-04-04
Completion
2019-04-04

Countries

  • Burma

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03578133 on ClinicalTrials.gov